Wellness Tier Procedure Category

Medical Weight Loss

GLP-1 programs, compounded semaglutide and tirzepatide, physician-supervised plans

The fastest-growing cash-pay healthcare category in 2024-2026. Brand-name GLP-1 medications (Wegovy, Zepbound) run $1,000 to $1,400 per month at retail, while compounded semaglutide and tirzepatide from 503A and 503B pharmacies typically run $199 to $499 monthly through telehealth weight-loss programs. As of mid-2025, FDA shortage status for both molecules ended, which is reshaping the compounding landscape and creating significant patient confusion about access and legitimacy.

Regulatory Notice

GLP-1 medications are FDA-approved on-label (Wegovy, Zepbound) or off-label (Ozempic, Mounjaro). Compounded versions exist in a complex regulatory space after the FDA shortage list resolution.

Cost range

$99 - $1,400

Procedures tracked

Metro markets

Cost pages

100

Procedures in Weight Loss

In-depth cost guides for the most-searched weight loss procedures.

Semaglutide for Weight Loss

Weekly GLP-1 receptor agonist injection that reduces appetite and food cravings, typically producing 12 to 17 percent body weight loss over 12 months.

National range $199 - $1,400

View costs →

Tirzepatide for Weight Loss

Weekly dual GIP/GLP-1 agonist injection delivering 18 to 22 percent body weight loss in 72 weeks, slightly outperforming semaglutide in head-to-head trials.

National range $250 - $1,300

View costs →